Validation of a Finnish version of the Fibromyalgia Impact Questionnaire (Finn-FIQ)

Scandinavian Journal of Pain

Volumn 3, Issue 1, 2012, Pages 15-20

  Gauffin, Jarno ^a   Hankama, Tiina ^b   Kautiainen, Hannu ^b,c   Arkela Kautiainen, Marja ^b   Hannonen, Pekka ^b   Haanpää, Maija ^a,d  

^a Kuntoutus ORTON   (Finland)

^b CENTRAL FINLAND CENTRAL HOSPITAL   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d Etera Mutual Pension Insurance Company   (Finland)

Author keywords

Fibromyalgia; Fibromyalgia Impact Questionnaire; Finn FIQ; ICF; Validation

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CHRONIC PAIN ACCEPTANCE QUESTIONNAIRE; CLINICAL ASSESSMENT TOOL; CONSTRUCT VALIDITY; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; FINLAND; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE SHORT FORM; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MEDICAL LEAVE; OUTCOME ASSESSMENT; PENSIONER; PRIORITY JOURNAL; QUESTIONNAIRE; RAND 36 ITEM HEALTH SURVEY; SCORING SYSTEM; STUDENT; UNEMPLOYMENT; VALIDITY; VISUAL ANALOG SCALE; WELLBEING;

EID: 84855757104     PISSN: 18778860     EISSN: 18778879     Source Type: Journal    
DOI: 10.1016/j.sjpain.2011.10.004     Document Type: Article

References (33)

1. White K.P., Harth M. Classification, epidemiology and natural history of fibromyalgia. Curr Pain Headache Rep 2001, 5:320-329.
2. Clauw D.J. Fibromyalgia: an overview. Am J Med 2009, 122:3-13.
3. Bigatti S.M., Hernandez A.M., Cronan T.A., Rand K.L. Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum Arthritis Care Res 2008, 59:961-967.
4. Abeles A.M., Pilliger M.H., Solitar B.M., Abeles M. Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med 2007, 146:726-734.
5. Annemans L., Le Lay K., Taïeb C. Societal and patient burden of fibromyalgia syndrome. Pharacoeconomics 2009, 27:547-559.
6. Burckhardt C., Clark S., Bennet R. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991, 18:728-733.
7. Hedin P.J., Hamne M., Burckhardt C.S., Engström-Laurent A. The Fibromyalgia Impact Questionnaire, a Swedish translation of new tool for evaluation of the fibromyalgia patient. Scand J Rheumatol 1996, 24:69-75.
8. Buskila D., Neumann L. Assessing functional disability and health status of women with fibromyalgia: validation of a Hebrew versions of the Fibromyalgia Impact Questionnaire. J Rheumatol 1996, 23:903-906.
9. Offenbaecher M., Waltz M., Shoeps P. Validation of a German version of the Fibromyalgia Impact Questionnaire (FIQ-G). J Rheumatol 2000, 27:1984-1988.
10. Sarmer S., Ergin S., Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 2000, 20:9-12.
11. Kim Y-A., Lee S-S., Park K. Validation of a Korean version of the Fibromyalgia Impact Questionnaire. J Korean Med Sci 2002, 17:220-224.
12. Bae S.C., Lee J.H. Cross-cultural adaptation and validation of the Korean Fibromyalgia Impact Questionnaire in women patients with fibromyalgia for clinical research. Qual Life Res 2004, 13:857-861.
13. Perrot S., Dumont D., Guilemin F., Pochot J., Coste J. and the French group for quality of life research: quality of life in women with fibromyalgia syndrome: validation of the QIF, the French version of the Fibromyalgia Questionnaire. J Rheumatol 2003, 30:1054-1059.
14. Sarzi-Puttini P., Atzeni F., Fiorini T., Panni B., Randisi G., Turiel M., Carrabba M. Validation of an Italian version of the Fibromyalgia Impact Questionnaire (FIQ-I). Clin Exp Rheumatol 2003, 21:459-464.
15. Rivera J., Gonzales T. The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol 2004, 22:554-560.
16. Rosado M.L., Pereira J.P., daFonseca J.P., Branco J.C. Cultural adaptation and validation of the Fibromyalgia Impact Questionnaire - Portuguese version. Acta Reumatol Port 2006, 31:157-165.
17. Zijlistra T.R., Taal E., vandeLaar M.A., Rasker J.J. Validation of a Dutch version of the Fibromyalgia Impact Questionnaire. Rheumatology (Oxford) 2007, 46:131-134.
18. Mease P.J. Further strategies for treating fibromyalgia: the role of serotonin and norepinephrine reuptake inhibitors. Am J Med 2009, 122:44-55.
19. Straube S., Derry S., Moore R.A., McQuay H.J. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports. Rheumatology 2010, 49:706-715.
20. WHO, World Health Organization International classification of functioning, disability and health, ICF 2001, World Health Organization, Geneva.
21. Cieza A., Geyh S., Chatterji S., Kostanjek N., Ustün B., Stucki G. ICF linking rules: an update based on lesions learned. J Rehabil Med 2005, 17:183-189.
22. Fries J.F., Spitz P., Kraines R.G., Holman H.R. Measurement of patient outcome in arthritis. Arthritis Rheum 1980, 23:137-145.
23. Hakala M., Nieminen P., Manelius J. Joint impairment is strongly correlated with disability measured by self-report questionnaires. Functional status assessment of individuals with rheumatoid arthritis in a population based series. J Rheumatol 1993, 21:64-69.
24. Hays R.D., Sherbourne C.D., Mazel R. The RAND 36-item Health Survey 1.0. Health Econ 1993, 2:217-277.
25. Aalto A-M, Aro S, Aro AR, Mähönen, M. RAND 36-item Health Survey 1.0. Suomenkielinen versio terveyteen liityvän elämänlaadun kyselystä. STAKESin Aiheita-sarja 2/1995 [RAND 36-item Health Survey 1.0 Finnish version of health related quality of life questionnaire] [in Finnish].
26. Schröder A., Oernboel E., Licht R.W., Sharpe M., Fink P. Outcome measurement in functional somatic syndromes: SF-36 summary scores and some scales were not valid. J Clin Epidemiol 2011, [Epub ahead of print].
27. Beck A.T., Steer R.A. Manual of the Beck Depression Inventory 1988, Psychology Corporation, San Antonio, TX.
28. Viinamäki H., Tanskanen A., Honkalampi K., Koivumaa-Honkanen H., Haatainen K., austio O., Hintikka J. Is the Beck Depression Inventory suitable for screening major depression in different phases of the disease?. Nord J Psychiatry 2004, 58:49-53.
29. McCracken L.M., Volwes K.E., Eccleston C. Acceptance of chronic pain: component analysis and revised assessment method. Pain 2004, 107:159-166.
30. Craig C.L., Marshal A.L., Sjöström M., Bauman A.E., Booth M.L., Ainsworth B.E., Pratt M., Ekelund U., Yngve A., Sallis J.F., Oja P. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003, 8:1381-1395.
31. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., Tugwell P., Campbell S.M., Abeles M., Clark P., Fam A.G., Farber S.J., Fiechtner J.J., Franklin C.M., Gatter R.A., Hamaty D., Lessard J., Lichtbroun A.S., Masi A.T., Mccain G.A., Reynolds W.J., Romano T.J., Russell I.J., Sheon R.P. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 1990, 33:160-172.
32. McVeigh J.G., Lucas A., Hurley D.A., Basford J.R., Baxter G.D. Patients' perception of exercise therapy in the treatment of fibromyalgia syndrome: a survey. Musculoskelet Care 2003, 1:98-107.
33. Creavin S.T., Dunn K.M., Mallen C.D., Nijroder I., van der Windt D.A. Co-occurrence and associations of pain and fatigue in a community sample of Dutch adults. Eur J Pain 2010, 14:327-334.